(Boursier.com) — Medtronic , one of the leaders in medical technologies, announced revenues of $8.6 billion for its fourth fiscal quarter, an increase of 0.5% on a consolidated basis and 5.4% on an organic basis. Adjusted earnings per share were $1.46 for the closed period. The consensus was for $1.45 in adjusted earnings per share on $8.44 billion in revenue. For the 2024 financial year, the group achieved revenues of $32.4 billion, an increase of 3.6%, for adjusted earnings per share of $5.20. Medtronic anticipates organic growth for fiscal year 2025 of between 4 and 5%. 2025 revenue growth on a reported basis is expected between 2.4 and 3.7%. The company expects 2025 adjusted earnings per share to be between $5.40 and $5.50. This would represent growth in adjusted diluted EPS for the year of around 4 to 6%.
©2024 Boursier.com